H. R. 6344—18
‘‘(A) facilitating cooperation among Federal, State, 
local, and tribal law enforcement agencies to share informa-
tion and implement coordinated enforcement activities; 
‘‘(B) enhancing law enforcement intelligence sharing 
among Federal, State, local, and tribal law enforcement 
agencies; 
‘‘(C) providing reliable law enforcement intelligence to 
law enforcement agencies needed to design effective 
enforcement strategies and operations; and 
‘‘(D) supporting coordinated law enforcement strategies 
which maximize use of available resources to reduce the 
supply of illegal drugs in designated areas and in the 
United States as a whole. 
‘‘(b) DESIGNATION.—
‘‘(1) IN GENERAL.—The Director, in consultation with the 
Attorney General, the Secretary of the Treasury, the Secretary 
of Homeland Security, heads of the National Drug Control 
Program agencies, and the Governor of each applicable State, 
may designate any specified area of the United States as a 
high intensity drug trafficking area. 
‘‘(2) ACTIVITIES.—After making a designation under para-
graph (1) and in order to provide Federal assistance to the 
area so designated, the Director may—
‘‘(A) obligate such sums as are appropriated for the 
Program; 
‘‘(B) direct the temporary reassignment of Federal per-
sonnel to such area, subject to the approval of the head 
of the department or agency that employs such personnel; 
‘‘(C) take any other action authorized under section 
704 to provide increased Federal assistance to those areas; 
and 
‘‘(D) coordinate activities under this section (specifically 
administrative, recordkeeping, and funds management 
activities) with State, local, and tribal officials. 
‘‘(c) PETITIONS FOR DESIGNATION.—The Director shall establish 
regulations under which a coalition of interested law enforcement 
agencies from an area may petition for designation as a high inten-
sity drug trafficking area. Such regulations shall provide for a 
regular review by the Director of the petition, including a rec-
ommendation regarding the merit of the petition to the Director 
by a panel of qualified, independent experts. 
‘‘(d) FACTORS FOR CONSIDERATION.—In considering whether to 
designate an area under this section as a high intensity drug 
trafficking area, the Director shall consider, in addition to such 
other criteria as the Director considers to be appropriate, the extent 
to which—
‘‘(1) the area is a significant center of illegal drug produc-
tion, manufacturing, importation, or distribution; 
‘‘(2) State, local, and tribal law enforcement agencies have 
committed resources to respond to the drug trafficking problem 
in the area, thereby indicating a determination to respond 
aggressively to the problem; 
‘‘(3) drug-related activities in the area are having a signifi-
cant harmful impact in the area, and in other areas of the 
country; and
H. R. 6344—19
‘‘(4) a significant increase in allocation of Federal resources 
is necessary to respond adequately to drug-related activities 
in the area. 
‘‘(e) ORGANIZATION
OF HIGH INTENSITY DRUG TRAFFICKING 
AREAS.—
‘‘(1) EXECUTIVE BOARD AND OFFICERS.—To be eligible for 
funds appropriated under this section, each high intensity drug 
trafficking area shall be governed by an Executive Board. The 
Executive Board shall designate a chairman, vice chairman, 
and any other officers to the Executive Board that it determines 
are necessary. 
‘‘(2) RESPONSIBILITIES.—The Executive Board of a high 
intensity drug trafficking area shall be responsible for—
‘‘(A) providing direction and oversight in establishing 
and achieving the goals of the high intensity drug traf-
ficking area; 
‘‘(B) managing the funds of the high intensity drug 
trafficking area; 
‘‘(C) reviewing and approving all funding proposals 
consistent with the overall objective of the high intensity 
drug trafficking area; and 
‘‘(D) reviewing and approving all reports to the Director 
on the activities of the high intensity drug trafficking area. 
‘‘(3) BOARD REPRESENTATION.—None of the funds appro-
priated under this section may be expended for any high inten-
sity drug trafficking area, or for a partnership or region of 
a high intensity drug trafficking area, if the Executive Board 
for such area, region, or partnership, does not apportion an 
equal number of votes between representatives of participating 
Federal agencies and representatives of participating State, 
local, and tribal agencies. Where it is impractical for an equal 
number of representatives of Federal agencies and State, local, 
and tribal agencies to attend a meeting of an Executive Board 
in person, the Executive Board may use a system of proxy 
votes or weighted votes to achieve the voting balance required 
by this paragraph. 
‘‘(4) NO
AGENCY
RELATIONSHIP.—The eligibility require-
ments of this section are intended to ensure the responsible 
use of Federal funds. Nothing in this section is intended to 
create an agency relationship between individual high intensity 
drug trafficking areas and the Federal Government. 
‘‘(f) USE OF FUNDS.—The Director shall ensure that no Federal 
funds appropriated for the Program are expended for the establish-
ment or expansion of drug treatment programs, and shall ensure 
that not more than 5 percent of the Federal funds appropriated 
for the Program are expended for the establishment of drug preven-
tion programs. 
‘‘(g) COUNTERTERRORISM ACTIVITIES.—
‘‘(1) ASSISTANCE AUTHORIZED.—The Director may authorize 
use of resources available for the Program to assist Federal, 
State, local, and tribal law enforcement agencies in investiga-
tions and activities related to terrorism and prevention of ter-
rorism, especially but not exclusively with respect to such inves-
tigations and activities that are also related to drug trafficking. 
‘‘(2) LIMITATION.—The Director shall ensure—
‘‘(A) that assistance provided under paragraph (1) 
remains incidental to the purpose of the Program to reduce
H. R. 6344—20
drug availability and carry out drug-related law enforce-
ment activities; and 
‘‘(B) that significant resources of the Program are not 
redirected to activities exclusively related to terrorism, 
except on a temporary basis under extraordinary cir-
cumstances, as determined by the Director. 
‘‘(h) ROLE
OF
DRUG
ENFORCEMENT
ADMINISTRATION.—The 
Director, in consultation with the Attorney General, shall ensure 
that a representative of the Drug Enforcement Administration is 
included in the Intelligence Support Center for each high intensity 
drug trafficking area. 
‘‘(i) ANNUAL HIDTA PROGRAM BUDGET SUBMISSIONS.—As part 
of the documentation that supports the President’s annual budget 
request for the Office, the Director shall submit to Congress a 
budget justification that includes—
‘‘(1) the amount proposed for each high intensity drug 
trafficking area, conditional upon a review by the Office of 
the request submitted by the HIDTA and the performance 
of the HIDTA, with supporting narrative descriptions and 
rationale for each request; 
‘‘(2) a detailed justification that explains—
‘‘(A) the reasons for the proposed funding level; how 
such funding level was determined based on a current 
assessment of the drug trafficking threat in each high 
intensity drug trafficking area; 
‘‘(B) how such funding will ensure that the goals and 
objectives of each such area will be achieved; and 
‘‘(C) how such funding supports the National Drug 
Control Strategy; and 
‘‘(3) the amount of HIDTA funds used to investigate and 
prosecute organizations and individuals trafficking in meth-
amphetamine in the prior calendar year, and a description 
of how those funds were used. 
‘‘(j) EMERGING THREAT RESPONSE FUND.—
‘‘(1) IN GENERAL.—Subject to the availability of appropria-
tions, the Director may expend up to 10 percent of the amounts 
appropriated under this section on a discretionary basis, to 
respond to any emerging drug trafficking threat in an existing 
high intensity drug trafficking area, or to establish a new 
high intensity drug trafficking area or expand an existing high 
intensity drug trafficking area, in accordance with the criteria 
established under paragraph (2). 
‘‘(2) CONSIDERATION OF IMPACT.—In allocating funds under 
this subsection, the Director shall consider—
‘‘(A) the impact of activities funded on reducing overall 
drug traffic in the United States, or minimizing the prob-
ability that an emerging drug trafficking threat will spread 
to other areas of the United States; and 
‘‘(B) such other criteria as the Director considers appro-
priate. 
‘‘(k) EVALUATION.—
‘‘(1) INITIAL
REPORT.—Not later than 90 days after the 
date of the enactment of this section, the Director shall, after 
consulting with the Executive Boards of each designated high 
intensity drug trafficking area, submit a report to Congress 
that describes, for each designated high intensity drug traf-
ficking area—
H. R. 6344—21
‘‘(A) the specific purposes for the high intensity drug 
trafficking area; 
‘‘(B) the specific long-term and short-term goals and 
objectives for the high intensity drug trafficking area; 
‘‘(C) the measurements that will be used to evaluate 
the performance of the high intensity drug trafficking area 
in achieving the long-term and short-term goals; and 
‘‘(D) the reporting requirements needed to evaluate 
the performance of the high intensity drug trafficking area 
in achieving the long-term and short-term goals. 
‘‘(2) EVALUATION OF HIDTA PROGRAM AS PART OF NATIONAL 
DRUG CONTROL STRATEGY.—For each designated high intensity 
drug trafficking area, the Director shall submit, as part of 
the annual National Drug Control Strategy report, a report 
that—
‘‘(A) describes—
‘‘(i) the specific purposes for the high intensity 
drug trafficking area; and 
‘‘(ii) the specific long-term and short-term goals 
and objectives for the high intensity drug trafficking 
area; and 
‘‘(B) includes an evaluation of the performance of the 
high intensity drug trafficking area in accomplishing the 
specific long-term and short-term goals and objectives 
identified under paragraph (1)(B). 
‘‘(l) ASSESSMENT OF DRUG ENFORCEMENT TASK FORCES IN HIGH 
INTENSITY DRUG TRAFFICKING AREAS.—Not later than 1 year after 
the date of enactment of this subsection, and as part of each 
subsequent annual National Drug Control Strategy report, the 
Director shall submit to Congress a report—
‘‘(1) assessing the number and operation of all federally 
funded drug enforcement task forces within each high intensity 
drug trafficking area; and 
‘‘(2) describing—
‘‘(A) each Federal, State, local, and tribal drug enforce-
ment task force operating in the high intensity drug traf-
ficking area; 
‘‘(B) how such task forces coordinate with each other, 
with any high intensity drug trafficking area task force, 
and with investigations receiving funds from the Organized 
Crime and Drug Enforcement Task Force; 
‘‘(C) what steps, if any, each such task force takes 
to share information regarding drug trafficking and drug 
production with other federally funded drug enforcement 
task forces in the high intensity drug trafficking area; 
‘‘(D) the role of the high intensity drug trafficking 
area in coordinating the sharing of such information among 
task forces; 
‘‘(E) the nature and extent of cooperation by each Fed-
eral, State, local, and tribal participant in ensuring that 
such information is shared among law enforcement agen-
cies and with the high intensity drug trafficking area; 
‘‘(F) the nature and extent to which information 
sharing and enforcement activities are coordinated with 
joint terrorism task forces in the high intensity drug traf-
ficking area; and
H. R. 6344—22
‘‘(G) any recommendations for measures needed to 
ensure that task force resources are utilized efficiently 
and effectively to reduce the availability of illegal drugs 
in the high intensity drug trafficking areas. 
‘‘(m) 
ASSESSMENT
OF
LAW
ENFORCEMENT
INTELLIGENCE 
SHARING IN HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.—
Not later than 180 days after the date of the enactment of this 
section, and as part of each subsequent annual National Drug 
Control Strategy report, the Director, in consultation with the 
Director of National Intelligence, shall submit to Congress a 
report—
‘‘(1) evaluating existing and planned law enforcement intel-
ligence systems supported by each high intensity drug traf-
ficking area, or utilized by task forces receiving any funding 
under the Program, including the extent to which such systems 
ensure access and availability of law enforcement intelligence 
to Federal, State, local, and tribal law enforcement agencies 
within the high intensity drug trafficking area and outside 
of it; 
‘‘(2) the extent to which Federal, State, local, and tribal 
law enforcement agencies participating in each high intensity 
drug trafficking area are sharing law enforcement intelligence 
information to assess current drug trafficking threats and 
design appropriate enforcement strategies; and 
‘‘(3) the measures needed to improve effective sharing of 
information and law enforcement intelligence regarding drug 
trafficking and drug production among Federal, State, local, 
and tribal law enforcement participating in a high intensity 
drug trafficking area, and between such agencies and similar 
agencies outside the high intensity drug trafficking area. 
‘‘(n) COORDINATION
OF
LAW
ENFORCEMENT
INTELLIGENCE 
SHARING WITH ORGANIZED CRIME DRUG ENFORCEMENT TASK FORCE 
PROGRAM.—The Director, in consultation with the Attorney General, 
shall ensure that any drug enforcement intelligence obtained by 
the Intelligence Support Center for each high intensity drug traf-
ficking area is shared, on a timely basis, with the drug intelligence 
fusion center operated by the Organized Crime Drug Enforcement 
Task Force of the Department of Justice. 
‘‘(o) USE
OF FUNDS TO COMBAT METHAMPHETAMINE TRAF-
FICKING.—
‘‘(1) REQUIREMENT.—As part of the documentation that sup-
ports the President’s annual budget request for the Office, 
the Director shall submit to Congress a report describing the 
use of HIDTA funds to investigate and prosecute organizations 
and individuals trafficking in methamphetamine in the prior 
calendar year. 
‘‘(2) CONTENTS.—The report shall include—
‘‘(A) the number of methamphetamine manufacturing 
facilities discovered through HIDTA-funded initiatives in 
the previous fiscal year; 
‘‘(B) the amounts of methamphetamine or listed chemi-
cals (as that term is defined in section 102(33) of the 
Controlled Substances Act (21 U.S.C. 802(33)) seized by 
HIDTA-funded initiatives in the area during the previous 
year; and
H. R. 6344—23
‘‘(C) law enforcement intelligence and predictive data 
from the Drug Enforcement Administration showing pat-
terns and trends in abuse, trafficking, and transportation 
in methamphetamine and listed chemicals. 
‘‘(3) CERTIFICATION.—Before the Director awards any funds 
to a high intensity drug trafficking area, the Director shall 
certify that the law enforcement entities participating in that 
HIDTA are providing laboratory seizure data to the national 
clandestine laboratory database at the El Paso Intelligence 
Center. 
‘‘(p) AUTHORIZATION OF APPROPRIATIONS.—There is authorized 
to be appropriated to the Office of National Drug Control Policy 
to carry out this section—
‘‘(1) $240,000,000 for fiscal year 2007; 
‘‘(2) $250,000,000 for fiscal year 2008; 
‘‘(3) $260,000,000 for fiscal year 2009; 
‘‘(4) $270,000,000 for fiscal year 2010; and 
‘‘(5) $280,000,000 for each of fiscal year 2011.’’. 
SEC. 302. FUNDING FOR CERTAIN HIGH INTENSITY DRUG TRAF-
FICKING AREAS. 
(a) SHORT TITLE.—This section may be cited as the ‘‘Dawson 
Family Community Protection Act’’. 
(b) FINDINGS.—Congress finds the following: 
(1) In the early morning hours of October 16, 2002, the 
home of Carnell and Angela Dawson was firebombed in 
apparent retaliation for Mrs. Dawson’s notification to police 
about persistent drug distribution activity in their East Balti-
more City neighborhood. 
(2) The arson claimed the lives of Mr. and Mrs. Dawson 
and their 5 young children, aged 9 to 14. 
(3) The horrific murder of the Dawson family is a stark 
example of domestic narco-terrorism. 
(4) In all phases of counternarcotics law enforcement—
from prevention to investigation to prosecution to reentry—
the voluntary cooperation of ordinary citizens is a critical 
component. 
(5) Voluntary cooperation is difficult for law enforcement 
officials to obtain when citizens feel that cooperation carries 
the risk of violent retaliation by illegal drug trafficking 
organizations and their affiliates. 
(6) Public confidence that law enforcement is doing all 
it can to make communities safe is a prerequisite for voluntary 
cooperation among people who may be subject to intimidation 
or reprisal (or both). 
(7) Witness protection programs are insufficient on their 
own to provide security because many individuals and families 
who strive every day to make distressed neighborhoods livable 
for their children, other relatives, and neighbors will resist 
or refuse offers of relocation by local, State, and Federal pros-
ecutorial agencies and because, moreover, the continued pres-
ence of strong individuals and families is critical to preserving 
and strengthening the social fabric in such communities. 
(8) Where (as in certain sections of Baltimore City) inter-
state trafficking of illegal drugs has severe ancillary local con-
sequences within areas designated as high intensity drug traf-
ficking areas, it is important that supplementary High Intensity
H. R. 6344—24
Drug Trafficking Areas Program funds be committed to support 
initiatives aimed at making the affected communities safe for 
the residents of those communities and encouraging their 
cooperation with tribal, local, State, and Federal law enforce-
ment efforts to combat illegal drug trafficking. 
(c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG TRAFFICKING 
AREAS.—Section 707, as amended by section 301, is amended by 
adding at the end the following: 
‘‘(q) SPECIFIC PURPOSES.—
‘‘(1) IN GENERAL.—The Director shall ensure that, of the 
amounts appropriated for a fiscal year for the Program, at 
least $7,000,000 is used in high intensity drug trafficking areas 
with severe neighborhood safety and illegal drug distribution 
problems. 
‘‘(2) REQUIRED
USES.—The funds used under paragraph 
(1) shall be used—
‘‘(A) to ensure the safety of neighborhoods and the 
protection of communities, including the prevention of the 
intimidation of potential witnesses of illegal drug distribu-
tion and related activities; and 
‘‘(B) to combat illegal drug trafficking through such 
methods as the Director considers appropriate, such as 
establishing or operating (or both) a toll-free telephone 
hotline for use by the public to provide information about 
illegal drug-related activities.’’. 
SEC. 303. ASSESSMENT. 
The Director shall assess the ability of the HIDTA Program 
to respond to the so-called ‘‘balloon effect’’, whereby urban drug 
traffickers facing intensive law enforcement efforts expand and 
spread their trafficking and distribution into rural, suburban, and 
smaller urban areas by conducting a demonstration project exam-
ining the ability of the New York/New Jersey HIDTA, with its 
new single colocated Organized Crime and Drug Enforcement Task 
Force/High Intensity Drug Trafficking Area Strike Force and 
HIDTA Regional Intelligence Center, to address the movement of 
drug traffickers into the more rural, suburban, and smaller areas 
encompassed by the counties of Albany, Onondaga, Monroe, and 
Erie in New York State and by annexing these counties into the 
existing New York/New Jersey HIDTA. 
TITLE IV—TECHNOLOGY 
SEC. 401. COUNTERDRUG TECHNOLOGY ASSESSMENT CENTER. 
(a) CHIEF SCIENTIST.—Section 708(b) is amended to read as 
follows: 
‘‘(b) CHIEF SCIENTIST.—There shall be at the head of the Center 
the Chief Scientist, who shall be appointed by the Director from 
among individuals qualified and distinguished in the area of science, 
medicine, engineering, or technology.’’. 
(b) RESPONSIBILITIES.—
(1) RESEARCH AND DEVELOPMENT.—Section 708 is amended 
by—
(A) redesignating subsection (d) as subsection (e); and 
(B) striking subsection (c) and inserting the following:
H. R. 6344—25
‘‘(c) RESEARCH
AND
DEVELOPMENT
RESPONSIBILITIES.—The 
Director, acting through the Chief Scientist, shall—
‘‘(1) identify and define the short-, medium-, and long-
term scientific and technological needs of Federal, State, local, 
and tribal drug supply reduction agencies, including—
‘‘(A) advanced surveillance, tracking, and radar 
imaging; 
‘‘(B) electronic support measures; 
‘‘(C) communications; 
‘‘(D) data fusion, advanced computer systems, and 
artificial intelligence; and 
‘‘(E) chemical, biological, radiological (including neu-
tron and electron), and other means of detection; 
‘‘(2) identify demand reduction basic and applied research 
needs and initiatives, in consultation with affected National 
Drug Control Program agencies, including—
‘‘(A) improving treatment through neuroscientific 
advances; 
‘‘(B) improving the transfer of biomedical research to 
the clinical setting; and 
‘‘(C) in consultation with the National Institute of Drug 
Abuse and the Substance Abuse and Mental Health Serv-
ices Administration, and through interagency agreements 
or grants, examining addiction and rehabilitation research 
and the application of technology to expanding the effective-
ness and availability of drug treatment; 
‘‘(3) make a priority ranking of such needs identified in 
paragraphs (1) and (2) according to fiscal and technological 
feasibility, as part of a National Counterdrug Research and 
Development Program; 
‘‘(4) oversee and coordinate counterdrug technology initia-
tives with related activities of other Federal civilian and mili-
tary departments; 
‘‘(5) provide support to the development and implementa-
tion of the national drug control performance measurement 
system established under subsection (c) of section 706; and 
‘‘(6) pursuant to the authority of the Director of National 
Drug Control Policy under section 704, submit requests to 
Congress for the reprogramming or transfer of funds appro-
priated for counterdrug technology research and development. 
‘‘(d) LIMITATION ON AUTHORITY.—The authority granted to the 
Director under this section shall not extend to the awarding of 
contracts, management of individual projects, or other operational 
activities.’’. 
(2) ASSISTANCE
AND
SUPPORT.—Subsection (e) of section 
708, as redesignated by this section, is amended to read as 
follows: 
‘‘(e) ASSISTANCE AND SUPPORT TO THE OFFICE OF NATIONAL 
DRUG CONTROL POLICY.—The Secretary of Defense, the Secretary 
of Homeland Security, and the Secretary of Health and Human 
Services shall, to the maximum extent practicable, render assistance 
and support to the Office and to the Director in the conduct of 
counterdrug technology assessment.’’. 
(3) TECHNOLOGY
TRANSFER
PROGRAM.—Section 708 is 
amended by adding at the end the following: 
‘‘(f) TECHNOLOGY TRANSFER PROGRAM.—